Neurobiology of Disease Synaptic Targeting by Alzheimer’s-Related Amyloid Oligomers

نویسندگان

  • Pascale N. Lacor
  • Maria C. Buniel
  • Lei Chang
  • Sara J. Fernandez
  • Yuesong Gong
  • Kirsten L. Viola
  • Mary P. Lambert
  • Pauline T. Velasco
  • Eileen H. Bigio
  • Caleb E. Finch
  • Grant A. Krafft
  • William L. Klein
چکیده

Pascale N. Lacor,1 Maria C. Buniel,1 Lei Chang,1 Sara J. Fernandez,1 Yuesong Gong,1 Kirsten L. Viola,1 Mary P. Lambert,1 Pauline T. Velasco,1 Eileen H. Bigio,2 Caleb E. Finch,3 Grant A. Krafft,4 and William L. Klein1 1Neurobiology and Physiology Department, Northwestern University, Evanston, Illinois 60208, 2Neuropathology Core, Northwestern Alzheimer’s Disease Center, Northwestern Feinberg School of Medicine, Chicago, Illinois 60611, 3Andrus Gerontology Center, University of Southern California, Los Angeles, California 90089, and 4Acumen Pharmaceuticals, Glenview, Illinois 60025

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Neurobiology of Disease -Amyloid Immunotherapy Prevents Synaptic Degeneration in a Mouse Model of Alzheimer’s Disease

Alzheimer’s disease neuropathology is characterized by key features that include the deposition of the amyloid peptide (A ) into plaques, the formation of neurofibrillary tangles, and the loss of neurons and synapses in specific brain regions. The loss of synapses, and particularly the associated presynaptic vesicle protein synaptophysin in the hippocampus and association cortices, has been wid...

متن کامل

Management of Alzheimer’s Disease: Role of Existing Therapies, Traditional Medicines and New Treatment Targets

Dementia, a common problem in elderly, is rising worldwide including India. Alzheimer’s disease is the main aetiology for dementia. Currently anticholinesterases, N-methyl-D-aspartate receptor antagonists, disease modifying agents form the mainstay of treatment of Alzheimer’s disease. However, recent breakthroughs in Alzheimer’s disease research have given multiple new treatment targets. This r...

متن کامل

High molecular mass assemblies of amyloid-b oligomers bind prion protein in patients with Alzheimer’s disease

Alzheimer’s disease is the most common form of dementia and the generation of oligomeric species of amyloid-b is causal to the initiation and progression of it. Amyloid-b oligomers bind to the N-terminus of plasma membrane-bound cellular prion protein (PrP) initiating a series of events leading to synaptic degeneration. Composition of bound amyloid-b oligomers, binding regions within PrP, bindi...

متن کامل

Cholinergic neuropathology in a mouse model of Alzheimer's disease

Transgenic mice over-expressing mutant human amyloid precursor protein (PDAPP mouse) develop several Alzheimer’s disease (AD)-like lesions including an age-related accumulation of amyloid-?-containing neuritic plaques. Although aged, heterozygous PDAPP mice also exhibit synaptic and glial cell changes, that is characteristic of AD pathology, no evidence of neurodegeneration has been observed. T...

متن کامل

Cholinergic neuropathology in a mouse model of Alzheimer's disease

Transgenic mice over-expressing mutant human amyloid precursor protein (PDAPP mouse) develop several Alzheimer’s disease (AD)-like lesions including an age-related accumulation of amyloid-?-containing neuritic plaques. Although aged, heterozygous PDAPP mice also exhibit synaptic and glial cell changes, that is characteristic of AD pathology, no evidence of neurodegeneration has been observed. T...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2004